This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Zacks Industry Outlook Highlights: Medpace Holdings, AMN Healthcare Services, LHC Group and Surgery Partners
by Zacks Equity Research
Zacks Industry Outlook Highlights: Medpace Holdings, AMN Healthcare Services, LHC Group and Surgery Partners
Near-Term Outlook Tepid for Medical Services Industry
by Urmimala Biswas
This sector witnesses growing demand for telemedicine-focused online medical services amid the pandemic.
Earnings Preview: AMN Healthcare Services (AMN) Q2 Earnings Expected to Decline
by Zacks Equity Research
AMN Healthcare (AMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Add AMN Healthcare to Your Portfolio
by Zacks Equity Research
Investor confidence is high in AMN Healthcare (AMN) stock, thanks to solid prospects.
Should Value Investors Buy AMN Healthcare Services (AMN) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
AMN Healthcare (AMN) Introduces New Customizable Offering
by Zacks Equity Research
AMN Healthcare (AMN) offers a customizable return-to-work solutions as businesses resume operations amid the ongoing pandemic.
Why Is AMN Healthcare (AMN) Up 28.2% Since Last Earnings Report?
by Zacks Equity Research
AMN Healthcare (AMN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
New Strong Sell Stocks for June 5th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Moving Average Crossover Alert: AMN Healthcare Services
by Zacks Equity Research
AMN Healthcare Services, Inc. (AMN) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
AMN Healthcare (AMN) Q1 Earnings In Line With Estimates
by Zacks Equity Research
AMN Healthcare (AMN) gained from core operating segments in Q1.
AMN Healthcare Services (AMN) Q1 Earnings Match Estimates
by Zacks Equity Research
AMN Healthcare (AMN) delivered earnings and revenue surprises of 0.00% and 0.13%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Why AMN Healthcare (AMN) Might Surprise This Earnings Season
by Zacks Equity Research
AMN Healthcare (AMN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What's in Store for Ensign Group's (ENSG) Earnings in Q1?
by Zacks Equity Research
Ensign Group's (ENSG) Q1 results are likely to reflect a better revenue stream.
What's in Store for GW Pharmaceuticals (GWPH) in Q1 Earnings?
by Zacks Equity Research
GW Pharmaceuticals (GWPH) might have registered slower international sales growth from procedural deferrals due to coronavirus pandemic in Q1.
AMN Healthcare Inks Deal to Address Healthcare System Needs
by Zacks Equity Research
This partnership is expected to boost AMN Healthcare's (AMN) Other Workforce Solutions segment.
Why AMN Healthcare (AMN) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
AMN Healthcare (AMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
5 Healthcare Stocks Poised to Beat Earnings Estimates in Q1
by Zacks Equity Research
Earnings results of healthcare sector are likely to reflect solid demand for its products and services from aging population and the growing incidence of COVID-19 illness.
Zacks Market Edge Highlights: Microsoft, Walmart, Chevron, Teladoc Health and AMN Healthcare Services
by Zacks Equity Research
Zacks Market Edge Highlights: Microsoft, Walmart, Chevron, Teladoc Health and AMN Healthcare Services
5 Stocks to Navigate the Coronavirus Earnings Season
by Tracey Ryniec
This will be an earnings season unlike any other. Where should stock investors be looking for safety and deals?
Here's Why You Should Retain AMN Healthcare (AMN) for Now
by Zacks Equity Research
Investor confidence remains high on AMN Healthcare's (AMN) stock, thanks to solid prospects.
Teladoc (TDOC) Catches Eye: Stock Jumps 12.2%
by Zacks Equity Research
Teladoc (TDOC) saw a big move last session, as its shares jumped more than 12% on the day, amid huge volumes.
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
AMN Healthcare (AMN) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
AMN Healthcare (AMN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why Is AMN Healthcare (AMN) Up 3.5% Since Last Earnings Report?
by Zacks Equity Research
AMN Healthcare (AMN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Has AMN Healthcare Services (AMN) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (AMN) Outperforming Other Medical Stocks This Year?